Regulatory Affairs for Medical Devices

Successfully bringing a medical device to market requires a deep understanding of global regulatory frameworks, evolving compliance expectations, and market‑specific requirements. Masuu Global Solutions offers specialized Regulatory Affairs for Medical Devices services that guide manufacturers through every stage—from early product concept to global market entry.

Our experts ensure that your device meets all relevant regulations and standards while accelerating approval timelines and reducing compliance risks.

Regulatory Affairs for Medical Devices – Overview

Masuu Global Solutions delivers comprehensive regulatory support for medical devices and In Vitro Diagnostic (IVD) products across global regions. Our highly skilled regulatory professionals provide strategic guidance and hands-on execution across the entire product lifecycle, including:

  • Development
  • Performance testing
  • Validation
  • Manufacturing
  • Labeling
  • Registration
  • Distribution

We support manufacturers, developers, importers, and distributors in achieving full regulatory alignment for entry into markets across the EU, US, UK, APAC, LATAM, Middle East, and more.

How Masuu Supports Global Regulatory Compliance

Our services ensure seamless compliance with regulations such as:

  • EU MDR & IVDR
  • FDA 21 CFR Part 820 / QMSR
  • Health Canada
  • UK MHRA
  • Australia TGA
  • PMDA Japan
  • NMPA China
  • SFDA Saudi Arabia
  • And other global regulatory bodies

We simplify regulatory complexity through cross‑functional expertise, timely guidance, and high‑quality technical documentation.

Masuu’s Regulatory Affairs Service Portfolio

1. Device Documentation

Preparation, review, and maintenance of regulatory documents, including:

  • Technical files
  • Design dossiers
  • GSPR checklists
  • Device descriptions
  • Clinical/performance evidence summaries

2. Labeling Services

  • Global labeling strategy
  • Regulatory review & approval
  • Multilingual label development
  • UDI compliance (EU, US, UK, China, etc.)

3. Technical Writing Services

  • CER/PER support
  • PMPF/PMCF plans
  • Risk management documentation
  • SSCP & SSP
  • PMSR, PSUR, and lifecycle reporting

4. RA Staff Augmentation

Masuu provides experienced RA professionals—onshore, offshore, or hybrid—to strengthen your internal regulatory workforce.

5. Regulatory Consulting

  • Global RA strategy
  • Market entry pathways
  • Regulatory impact assessments
  • Change management for device updates
  • NB/HA communication & deficiency response

6. Human Factors Engineering (HFE)

  • Usability engineering files
  • Validation study design
  • HF test protocols & reports
  • MDR/IVDR‑aligned HFE documentation

7. Market Intelligence Services

  • Country‑specific regulatory research
  • Competitor landscape comparison
  • Regulatory change monitoring
  • Product classification insights

8. Medical & Scientific Communication

  • Scientific writing
  • Clinical summaries
  • Regulatory response dossiers
  • Evidence positioning

9. Mergers & Acquisitions Regulatory Support

  • Regulatory due diligence
  • Compliance risk assessments
  • Labeling & documentation harmonization
  • Transition planning

10. Biocompatibility Services

  • ISO 10993 strategy & testing guidance
  • Gap analysis & risk assessments
  • Test plan development
  • Documentation preparation for submissions

Why Partner with Masuu Global Solutions?

  • Deep global expertise across medical devices & IVDs
  • End‑to‑end regulatory lifecycle support
  • Cross‑functional teams spanning RA, QA, HFE, clinical, and labeling
  • Proven success across all device classes—from Class I to Class III
  • Scalable staffing options for rapid regulatory execution
  • Strong multilingual capabilities for international submissions
  • High‑quality documentation that is Notified Body & FDA ready

Frequently Asked Questions

Medical device regulatory affairs involves managing the regulatory requirements a device must meet before and after entering a market. It can cover product development, performance testing, validation, manufacturing, labeling, registration, distribution, and post-market activities, with requirements varying according to the device, market, and applicable regulatory framework.

Regulatory strategy helps determine how a medical device should progress through development, assessment, registration, and commercialization. It considers factors such as device classification, intended market, technical documentation, performance evidence, labeling, and applicable regulatory requirements. A suitable strategy helps establish which regulatory pathway and documentation are relevant.

Medical device requirements vary between jurisdictions. The source identifies frameworks and authorities including EU MDR and IVDR, U.S. FDA requirements, Health Canada, UK MHRA, Australia TGA, Japan PMDA, China NMPA, and Saudi Arabia SFDA. The applicable requirements depend on the target market, device type, and regulatory classification.

Medical device classification determines the regulatory category assigned to a device based on applicable rules and characteristics. Classification is important because it can influence the evidence, documentation, conformity assessment, and submission pathway required before market entry. The source highlights classification as an important part of regulatory strategy and market entry.

Medical device regulatory documentation can include technical files, design dossiers, GSPR checklists, device descriptions, and clinical or performance evidence summaries. The specific documents required depend on the regulatory framework, device classification, intended use, and target market. Documentation must be prepared and maintained according to applicable regulatory requirements.

Medical device labeling communicates information required for the safe and appropriate use of a device. Regulatory labeling activities can include label development, regulatory review, multilingual labeling, and Unique Device Identification requirements. The applicable labeling requirements depend on the target market and regulatory framework governing the device.

Unique Device Identification, or UDI, is a system used to identify medical devices through standardized identification information. The source identifies UDI compliance as part of medical device labeling activities across markets including the EU, United States, United Kingdom, and China. Specific UDI requirements depend on the applicable jurisdiction.

Clinical and performance evidence provides information used to support the safety, performance, and intended use of a medical device. The source includes clinical and performance evidence summaries within regulatory documentation and identifies clinical support as part of regulatory activities. The evidence required depends on the device and applicable regulatory pathway.

Post-market surveillance involves monitoring a medical device after it has entered the market. It can include activities such as PMS documentation, periodic reporting, vigilance activities, and lifecycle management. These activities help organizations continue monitoring device performance and safety while addressing applicable regulatory requirements after market entry.

Regulatory lifecycle management covers regulatory activities throughout a device’s development and commercial lifecycle. It can include initial strategy, documentation, registration, labeling, regulatory changes, post-market activities, and updates to approved information. Managing these activities throughout the lifecycle helps maintain alignment between the device, its documentation, and applicable regulatory requirements.

Book a Demo